HD-OPM Archive
Topics › Cancer

FDA approves Shield blood test for colon cancer, less sensitive than colonoscopy

Louis Nervegna · Jul 29, 2024 · ♥ 11 reactions · 2 comments · original Facebook post
CancerRisk assessment & lab tests
AI summary & key facts

A news share on the FDA approval of Guardant's Shield blood test for colorectal cancer screening. It is less effective than colonoscopy at detecting precancerous or early cancers, but may reach people who refuse colonoscopy.

The FDA has approved a blood test for colon cancer.

It just requires a simple blood draw. That’s it.

Quoted:

“The test, called Shield and made by Guardant Health, a Palo Alto, Calif.-based biotech firm, comes with a drawback: It is not as good as a colonoscopy and other tests at detecting precancerous or early stage cancers. But some experts have welcomed it as a way to approach another problem: As effective as colonoscopy is as both a way of finding cancer and removing lesions that could become cancer later on, many people are unwilling to undergo the procedure.”

Shared from STAT · original post

The FDA approved a blood test intended to detect colon cancer, which many experts hope will help catch cases of the disease early enough so that they can be more easily treated.

#cancer#bloodtests#coloncancer
← newer: PROVE IT-TIMI 22: atorvastatin 80 mg early after a heart attolder: NMR reports state LDL particle size adds no risk information →